↓ Skip to main content

Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis

Overview of attention for article published in Frontiers in oncology, October 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Readers on

mendeley
19 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dimethylaminomicheliolide (DMAMCL) Suppresses the Proliferation of Glioblastoma Cells via Targeting Pyruvate Kinase 2 (PKM2) and Rewiring Aerobic Glycolysis
Published in
Frontiers in oncology, October 2019
DOI 10.3389/fonc.2019.00993
Pubmed ID
Authors

Jianshuang Guo, Qingqing Xue, Kaihui Liu, Weizhi Ge, Wenjie Liu, Jiyan Wang, Mengyi Zhang, Qiu-ying Li, Dongpo Cai, Changliang Shan, Chunze Zhang, Xinqi Liu, Jing Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 4 21%
Other 2 11%
Student > Ph. D. Student 2 11%
Student > Master 2 11%
Student > Doctoral Student 1 5%
Other 2 11%
Unknown 6 32%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 26%
Pharmacology, Toxicology and Pharmaceutical Science 2 11%
Agricultural and Biological Sciences 1 5%
Medicine and Dentistry 1 5%
Neuroscience 1 5%
Other 1 5%
Unknown 8 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 October 2019.
All research outputs
#20,266,762
of 25,774,185 outputs
Outputs from Frontiers in oncology
#9,495
of 22,796 outputs
Outputs of similar age
#262,749
of 364,394 outputs
Outputs of similar age from Frontiers in oncology
#228
of 460 outputs
Altmetric has tracked 25,774,185 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,796 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,394 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 460 others from the same source and published within six weeks on either side of this one. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.